Urinary neutrophil gelatinase-associated lipocalin and L-type fatty acid binding protein as diagnostic markers of early acute kidney injury after liver transplantation

Biomarkers

Volumn 17, Issue 4, 2012, Pages 336-342

  Li, Yi ^a   Zhu, Mingli ^a   Xia, Qiang ^b   Wang, Siyue ^b   Qian, Jiaqi ^a   Lu, Renhua ^a   Che, Miaolin ^a   Dai, Huili ^a   Wu, Qingwei ^a   Ni, Zhaohui ^a   Lindholm, Bengt ^c   Axelsson, Jonas ^c   Yan, Yucheng ^a  

^a Renal Division   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Growth factors cytokines inflammatory mediators; Oxidative stress; Renal disease

Indexed keywords

BIOLOGICAL MARKER; FATTY ACID BINDING PROTEIN; L TYPE FATTY ACID BINDING PROTEIN; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; KIDNEY INJURY; LIVER TRANSPLANTATION; MALE; QUANTITATIVE ANALYSIS; RECEIVER OPERATING CHARACTERISTIC; URINALYSIS;

ACUTE KIDNEY INJURY; ACUTE-PHASE PROTEINS; ADULT; AREA UNDER CURVE; BIOLOGICAL MARKERS; CREATININE; END STAGE LIVER DISEASE; FATTY ACID-BINDING PROTEINS; FEMALE; HUMANS; LIPOCALINS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; POSTOPERATIVE PERIOD; PROSPECTIVE STUDIES; PROTO-ONCOGENE PROTEINS; ROC CURVE;

EID: 84861592035     PISSN: 1354750X     EISSN: 13665804     Source Type: Journal    
DOI: 10.3109/1354750X.2012.672458     Document Type: Article

References (36)

1. Bachorzewska-Gajewska H, Malyszko J, Sitniewska E, Malyszko JS, Dobrzycki S. (2006). Neutrophil-gelatinase-associated lipocalin and renal function after percutaneous coronary interventions. Am J Nephrol 26:287-292.
2. Barri YM, Sanchez EQ, Jennings LW, Melton LB, Hays S, Levy MF, Klintmalm GB. (2009). Acute kidney injury following liver transplantation: definition and outcome. Liver Transpl 15:475-483.
3. Cowland JB, Sørensen OE, Sehested M, Borregaard N. (2003). Neutrophil gelatinase-associated lipocalin is up-regulated in human epithelial cells by IL-1 beta, but not by TNF-alpha. J Immunol 171:6630-6639.
4. Fjaertoft G, Foucard T, Xu S, Venge P. (2005). Human neutrophil lipocalin (HNL) as a diagnostic tool in children with acute infections: a study of the kinetics. Acta Paediatr 94:661-666.
5. Glatz JF, van der Vusse GJ. (1996). Cellular fatty acid-binding proteins: their function and physiological significance. Prog Lipid Res 35:243-282.
6. Hirsch R, Dent C, Pfriem H, Allen J, Beekman RH 3rd, Ma Q, Dastrala S, Bennett M, Mitsnefes M, Devarajan P. (2007). NGAL is an early predictive biomarker of contrast-induced nephropathy in children. Pediatr Nephrol 22:2089-2095.
7. Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL, D'Amico G, Dickson ER, Kim WR. (2001). A model to predict survival in patients with end-stage liver disease. Hepatology 33:464-470.
8. Kamijo A, Sugaya T, Hikawa A, Yamanouchi M, Hirata Y, Ishimitsu T, Numabe A, Takagi M, Hayakawa H, Tabei F, Sugimoto T, Mise N, Omata M, Kimura K. (2006). Urinary liver-type fatty acid binding protein as a useful biomarker in chronic kidney disease. Mol Cell Biochem 284:175-182.
9. Kamijo-Ikemori A, Sugaya T, Obama A, Hiroi J, Miura H, Watanabe M, Kumai T, Ohtani-Kaneko R, Hirata K, Kimura K. (2006). Livertype fatty acid-binding protein attenuates renal injury induced by unilateral ureteral obstruction. Am J Pathol 169:1107-1117.
10. Kjeldsen L, Johnsen AH, Sengeløv H, Borregaard N. (1993). Isolation and primary structure of NGAL, a novel protein associated with human neutrophil gelatinase. J Biol Chem 268:10425-10432.
11. Mehta RL, Kellum JA, Shah SV, Molitoris BA, Ronco C, Warnock DG, Levin A; Acute Kidney Injury Network. (2007). Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care 11:R31.
12. Menon KVN, Nyberg SL, Harmsen WS, DeSouza NF, Rosen CB, Krom RA, Wiesner RH. (2004). MELD and other factors associated with survival after liver transplantation. Am J Transplant 4:819-825.
13. Mishra J, Ma Q, Prada A, Mitsnefes M, Zahedi K, Yang J, Barasch J, Devarajan P. (2003). Identification of neutrophil gelatinaseassociated lipocalin as a novel early urinary biomarker for ischemic renal injury. J Am Soc Nephrol 14:2534-2543.
14. Mishra J, Mori K, Ma Q, Kelly C, Barasch J, Devarajan P. (2004). Neutrophil gelatinase-associated lipocalin: a novel early urinary biomarker for cisplatin nephrotoxicity. Am J Nephrol 24:307-315.
15. Mishra J, Dent C, Tarabishi R, Mitsnefes MM, Ma Q, Kelly C, Ruff SM, Zahedi K, Shao M, Bean J, Mori K, Barasch J, Devarajan P. (2005). Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Lancet 365:1231-1238.
16. Monbaliu D, de Vries B, Crabbé T, van Heurn E, Verwaest C, Roskams T, Fevery J, Pirenne J, Buurman WA. (2005). Liver fatty acid-binding protein: an early and sensitive plasma marker of hepatocellular damage and a reliable predictor of graft viability after liver transplantation from non-heart-beating donors. Transplant Proc 37:413-416.
17. Mori K, Lee HT, Rapoport D, Drexler IR, Foster K, Yang J, Schmidt-Ott KM, Chen X, Li JY, Weiss S, Mishra J, Cheema FH, Markowitz G, Suganami T, Sawai K, Mukoyama M, Kunis C, D'Agati V, Devarajan P, Barasch J. (2005). Endocytic delivery of lipocalin-siderophoreiron complex rescues the kidney from ischemia-reperfusion injury. J Clin Invest 115:610-621.
18. Nakamura T, Sugaya T, Ebihara I, Koide H. (2005a). Urinary livertype fatty acid-binding protein: discrimination between IgA nephropathy and thin basement membrane nephropathy. Am J Nephrol 25:447-450.
19. Nakamura T, Sugaya T, Kawagoe Y, Ueda Y, Osada S, Koide H. (2005b). Efect of pitavastatin on urinary liver-type fatty acid-binding protein levels in patients with early diabetic nephropathy. Diabetes Care 28:2728-2732.
20. Nakamura T, Sugaya T, Kawagoe Y, Ueda Y, Koide H. (2006a). Effect of pioglitazone on urinary liver-type fatty acid-binding protein concentrations in diabetes patients with microalbuminuria. Diabetes Metab Res Rev 22:385-389.
21. Nakamura T, Sugaya T, Node K, Ueda Y, Koide H. (2006b). Urinary excretion of liver-type fatty acid-binding protein in contrast medium-induced nephropathy. Am J Kidney Dis 47:439-444.
22. Negishi K, Noiri E, Sugaya T, Li S, Megyesi J, Nagothu K, Portilla D. (2007). A role of liver fatty acid-binding protein in cisplatininduced acute renal failure. Kidney Int 72:348-358.
23. Niemann CU, Walia A, Waldman J, Davio M, Roberts JP, Hirose R, Feiner J. (2009). Acute kidney injury during liver transplantation as determined by neutrophil gelatinase-associated lipocalin. Liver Transpl 15:1852-1860.
24. Orlando R, Mussap M, Plebani M, Piccoli P, De Martin S, Floreani M, Padrini R, Palatini P. (2002). Diagnostic value of plasma cystatin C as a glomerular filtration marker in decompensated liver cirrhosis. Clin Chem 48:850-858.
25. Park Y, Hirose R, Dang K, Xu F, Behrends M, Tan V, Roberts JP, Niemann CU. (2008). Increased severity of renal ischemia-reperfusion injury with venous clamping compared to arterial clamping in a rat model. Surgery 143:243-251.
26. Pelsers MM, Morovat A, Alexander GJ, Hermens WT, Trull AK, Glatz JF. (2002). Liver fatty acid-binding protein as a sensitive serum marker of acute hepatocellular damage in liver transplant recipients. Clin Chem 48:2055-2057.
27. Playford RJ, Belo A, Poulsom R, Fitzgerald AJ, Harris K, Pawluczyk I, Ryon J, Darby T, Nilsen-Hamilton M, Ghosh S, Marchbank T. (2006). Effects of mouse and human lipocalin homologues 24p3/lcn2 and neutrophil gelatinase-associated lipocalin on gastrointestinal mucosal integrity and repair. Gastroenterology 131:809-817.
28. Portal AJ, McPhail MJ, Bruce M, Coltart I, Slack A, Sherwood R, Heaton ND, Shawcross D, Wendon JA, Heneghan MA. (2010). Neutrophil gelatinase- associated lipocalin predicts acute kidney injury in patients undergoing liver transplantation. Liver Transpl 16:1257-1266.
29. Portilla D, Dent C, Sugaya T, Nagothu KK, Kundi I, Moore P, Noiri E, Devarajan P. (2008). Liver fatty acid-binding protein as a biomarker of acute kidney injury after cardiac surgery. Kidney Int 73:465-472.
30. Saito A, Pietromonaco S, Loo AK, Farquhar MG. (1994). Complete cloning and sequencing of rat gp330/"megalin," a distinctive member of the low density lipoprotein receptor gene family. Proc Natl Acad Sci USA 91:9725-9729.
31. Schrier RW, Wang W, Poole B, Mitra A. (2004). Acute renal failure: definitions, diagnosis, pathogenesis, and therapy. J Clin Invest 114:5-14.
32. Wagener G, Jan M, Kim M, Mori K, Barasch JM, Sladen RN, Lee HT. (2006). Association between increases in urinary neutrophil gelatinase-associated lipocalin and acute renal dysfunction after adult cardiac surgery. Anesthesiology 105:485-491.
33. Wagener G, Minhaz M, Mattis FA, Kim M, Emond JC, Lee HT. (2011). Urinary neutrophil gelatinase-associated lipocalin as a marker of acute kidney injury after orthotopic liver transplantation. Nephrol Dial Transplant 26:1717-1723.
34. Yamamoto T, Noiri E, Ono Y, Doi K, Negishi K, Kamijo A, Kimura K, Fujita T, Kinukawa T, Taniguchi H, Nakamura K, Goto M, Shinozaki N, Ohshima S, Sugaya T. (2007). Renal L-type fatty acid-binding protein in acute ischemic injury. J Am Soc Nephrol 18:2894-2902.
35. Zager RA, Johnson AC, Hanson SY. (2005). Renal tubular triglyercide accumulation following endotoxic, toxic, and ischemic injury. Kidney Int 67:111-121.
36. Zappitelli M, Washburn KK, Arikan AA, Loftis L, Ma Q, Devarajan P, Parikh CR, Goldstein SL. (2007). Urine neutrophil gelatinaseassociated lipocalin is an early marker of acute kidney injury in critically ill children: a prospective cohort study. Crit Care 11:R84.